DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	LILRA5; NLRP10; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	4	37	10.8108108108108	0.00010620637712943	0.00227332221522294	0.0911250715770564	0.0954795330393633	0.089319563165856	0.0911250715770564	0.0167749691355096
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0001114965563268	0.00233105591018138	0.0955525487720733	0.100235404137799	0.0936571073145176	0.0955525487720733	0.0172009892326702
down	XCL2; CXCR1; PF4; CXCL11; PF4V1;	GO:0030593~neutrophil chemotaxis	5	76	6.57894736842105	0.00013022365265569	0.00266070599403335	0.111471446673272	0.117071063737467	0.10730428978829	0.111471446673272	0.0196334952562797
up	EGFR; KRT6A; ERBB2; SERPINB2; DCN; GLI3; SDC1; FGFR2; ERBB3; CDH3; LOX; SDC4; OPRM1; WNT5A; EPPK1; GRHL3; NOTCH4; WNT5B; DSP; EVPL; PPL;	GO:0042060~wound healing	21	82	25.609756097561	0.00035720278255801	0.374218085381122	1	1	0.988434111146133	0.999999999995672	1
down	TYROBP; NCR1; MNDA; CCR2;	GO:0006968~cellular defense response	4	53	7.54716981132075	0.00038428887531738	0.00699336181466424	0.327029832895094	0.345475698910329	0.226977678241945	0.327029832895094	0.0516043998553629
down	TYROBP; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	3	21	14.2857142857143	0.00038895227000357	0.00699336181466424	0.330609429503037	0.349668090733212	0.228314982492097	0.330609429503037	0.0516043998553629
up	TRGJ1; TRAV6; TRAV23DV6; TRAV18; TRAJ3; TRAJ42; TRAV30; TRBV16; TRBJ2-7; TRAV14DV4; TRBV6-8; TRAV8-3; TRAV16; TRAV19; TRAV13-2; TRAV8-2; TRAV10; TRAV12-1; TRAV8-6; TRAV39; TRAV38-1; TRAV41; TRAV4; TRAV12-3; TRAV34; TRAV17; TRAV25; TRAV22; TRBJ1-3; TRBJ1-6; TRBJ1-4; TRBV7-7; TRBV7-6; TRDV1; TRBV7-4; TRBV11-3; TRBV14; TRBV29-1; TRAV38-2DV8; TNFRSF21; ANXA1; CD3G; TRGC1; TRBD1; CD1E; CTLA4; IL2; ARG2; SLAMF1; ADGRE1; TRAT1; SKAP1; CLEC4C; CD209; CD84; TNFSF18; IFNG; IFNA5;	GO:0002250~adaptive immune response	58	347	16.7146974063401	0.00041331796485655	0.374218085381122	1	1	0.999999999995672	0.999999999995672	1
down	CLDN5; TYROBP; AGR2; PF4; AZU1; MMP8; SLC26A9; TESC; NAT8B;	GO:0010628~positive regulation of gene expression	9	374	2.40641711229947	0.00055176789466371	0.0095392180250515	0.467899174674828	0.496039337302678	0.279042018771475	0.467899174674828	0.0703904122678196
down	MYL3; MYH6; TNNC1;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.00061851376253585	0.010491393821127	0.523881156867869	0.556043872519734	0.299741026365366	0.523881156867869	0.0774165696175292
up	ERBB2; ERBB3; BDKRB2; TRAT1; CNKSR1; NRTN; MET; FRK; BCAR1; KDR; SLA; EGFR; DDR1; PTK6; FGFR3; CLNK; EPHB3; TYRO3; ROR2; EPHA2; EPHA1; FGFR2; NTRK2; FGFR4; ROR1; EFS;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	26	120	21.6666666666667	0.00071111408031387	0.531056629677907	1	1	0.999999999995672	0.999999999995672	1
down	ICAM3; MUC3A; CLEC10A; MUC13; CLEC4A;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.00071498390588231	0.0113214993489282	0.604876384376439	0.642770531388202	0.329607580611748	0.604876384376439	0.0835419637718789
down	F13A1; GP9; GATA1; PRTN3; P2RX1; F2RL3;	GO:0007596~blood coagulation	6	171	3.50877192982456	0.00072327209998934	0.0113214993489282	0.611164924490998	0.650221617890423	0.331990199270517	0.611164924490998	0.0835419637718789
down	KRT14; KRT4; KRT20; KRT17; SPRR3;	GO:0070268~cornification	5	113	4.42477876106195	0.00074301274926225	0.0113214993489282	0.624873722129553	0.667968461586763	0.337401603234657	0.624873722129553	0.0835419637718789
up	AGPAT2; TGM5; SCEL; GJB5; KRT5; DSP; KRT15; CRABP2; DCT; ALDH3A2; EMP1; ELF3; CST6; ZNF750; GRHL2; CERS3; GRHL3; EVPL; GRHL1; POU2F3;	GO:0008544~epidermis development	20	82	24.390243902439	0.00082116112386687	0.531056629677907	1	1	0.999999999995672	0.999999999995672	1
down	CTSV; ELANE; CTSG; MMP8;	GO:0022617~extracellular matrix disassembly	4	66	6.06060606060606	0.00083934663377083	0.0125762103959996	0.705051172367499	0.754572623759978	0.356722319352604	0.705051172367499	0.0928005453084792
down	CXCL11; CD19; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	3	29	10.3448275862069	0.00092005939555561	0.0135595638787623	0.771929832871163	0.8271333966045	0.372678843304001	0.771929832871163	0.100056764515848
down	AZU1; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	4	74	5.40540540540541	0.0012578868778681	0.017949846082594	1	1	0.433160998768794	0.9271750609515	0.132452897352755
down	LILRA5; FABP4; CCR2; NLRP10;	GO:0050729~positive regulation of inflammatory response	4	78	5.12820512820513	0.0015138842917195	0.0210778933565484	1	1	0.470818014724765	0.9271750609515	0.155534929509756
down	LTF; DEFA4; DEFA3;	GO:0031640~killing of cells of other organism	3	35	8.57142857142857	0.0015239856153233	0.0210778933565484	1	1	0.472281760587609	0.9271750609515	0.155534929509756
up	TRPA1; TSPAN12; EGFR; F2; PRL; IFNG; IL2RA; ERBB2; MET; CD3G; CCL2; CD59; EDN3; NPR1; EDN2; EPHA1; EDNRB; BDKRB2; GLP1R; P2RY1; CCR5; GEM; ADGRE1; ADGRF1; GPR157; ADGRG6; ADGRF5; ADGRF4; ADGRV1; MAGI1; CD80; TRBV7-1; TRBV6-8; TRBV17; TRBV11-3; TRBV7-6; TRBV29-1; TRBV7-7; TRBV14; TRBV5-7; TRBV6-7; TRBV7-4; TRBV16; TRBV23-1; ANXA1;	GO:0007166~cell surface receptor signaling pathway	45	268	16.7910447761194	0.0015717626313535	0.667842220545278	1	1	0.999999999995672	0.999999999995672	1
up	DSP; DSG2; GRHL1; PKP2; PERP;	GO:0002934~desmosome organization	5	6	83.3333333333333	0.0018136118780181	0.667842220545278	1	1	0.999999999995672	0.999999999995672	1
up	OVOL1; SNAI2; FBLN1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	5	6	83.3333333333333	0.0018136118780181	0.667842220545278	1	1	0.999999999995672	0.999999999995672	1
up	PRSS37; FOXE1; PLXNB1; CDK1; PTPRF; CEACAM1; JUP; HOXA5; EFNA1; FGFR4; CD24; EPHA2; BDKRB1; EPHB3; EMP2; BCAR1; SHROOM2; PTK6; DOCK1; HES1; SKAP1; WWC1; ASAP3; DEPDC1B; RHBDF1; FAM83D; TYRO3; KDR; SDC1; GPC1; LAMB2; ITGB6; PIK3C2G; NCKAP1L; RHOV; EFS; SDC4; NCKAP1; RHOD;	GO:0016477~cell migration	39	225	17.3333333333333	0.00189052053940464	0.667842220545278	1	1	0.999999999995672	0.999999999995672	1
down	MYL3; MYH6; TNNC1;	GO:0030049~muscle filament sliding	3	38	7.89473684210526	0.00190048417789446	0.0227804703456949	1	1	0.51888846078501	0.9271750609515	0.168098338362451
down	P2RX1; UNC13C; GRIN2B;	GO:0035249~synaptic transmission, glutamatergic	3	38	7.89473684210526	0.00190048417789446	0.0227804703456949	1	1	0.51888846078501	0.9271750609515	0.168098338362451
down	TYROBP; FCGR2B; GRIN2B;	GO:1901216~positive regulation of neuron death	3	38	7.89473684210526	0.00190048417789446	0.0227804703456949	1	1	0.51888846078501	0.9271750609515	0.168098338362451
up	SNAI2; FGFR2; SFN; EFNB2; EPPK1; KDF1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	7	14	50	0.00191781507998423	0.667842220545278	1	1	0.999999999995672	0.999999999995672	1
down	GRIN2B; CCR8; CCR2; CXCR1;	GO:0019722~calcium-mediated signaling	4	85	4.70588235294118	0.00204550200048015	0.0238818999796319	1	1	0.531830520124839	0.9271750609515	0.176225847956342
down	CLDN5; PF4; CCR2; HHEX;	GO:0016525~negative regulation of angiogenesis	4	89	4.49438202247191	0.00240092078052956	0.0276721510473856	1	1	0.563910504765231	0.9271750609515	0.20419431817655
down	CA4; HBA1; SLC26A9;	GO:0015701~bicarbonate transport	3	42	7.14285714285714	0.00248569487333217	0.0282865783686787	1	1	0.571483770937573	0.9271750609515	0.208728211032427
down	FABP4; FCGR2B; CD79B; FER1L6;	GO:0009617~response to bacterium	4	92	4.34782608695652	0.00269381901948251	0.0291776301025877	1	1	0.587252546247188	0.9271750609515	0.215303330579658
down	RNASE3; DEFA4; DEFA3; RNASE6;	GO:0050830~defense response to Gram-positive bacterium	4	95	4.21052631578947	0.00301030444587558	0.0322174249624065	1	1	0.608081498066867	0.9271750609515	0.237734143339185
down	MYL3; MYH6; TNNC1;	GO:0060048~cardiac muscle contraction	3	46	6.52173913043478	0.00317115098839649	0.033149589983354	1	1	0.618346010550244	0.9271750609515	0.244612640083239
up	BMP4; BMP7; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	4	4	100	0.00357364133280158	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.00357364133280158	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	ORM1; BPI; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	3	49	6.12244897959184	0.00375411018989258	0.037920731019252	1	1	0.649461062851416	0.9271750609515	0.279819151101522
down	CXCL11; PF4; ADRA2A; ADGRE3;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	4	103	3.88349514563107	0.00397636423992176	0.0385837770796985	1	1	0.660294925877042	0.9271750609515	0.284711804296449
up	DBH; MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	5	8	62.5	0.00432555735773166	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SULT2B1; BMP4; SFN; KDF1; IL20;	GO:0045606~positive regulation of epidermal cell differentiation	5	8	62.5	0.00432555735773166	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	CNR2; CCR2; PROK2;	GO:0019233~sensory perception of pain	3	53	5.66037735849057	0.00462691742273036	0.0433291537816103	1	1	0.694507934379042	0.9271750609515	0.319728198883141
up	FOXE1; NGFR; FGFR2; IGFBP5; SOSTDC1; TMEM79; FOXQ1; TP63; INTU;	GO:0031069~hair follicle morphogenesis	9	28	32.1428571428571	0.0050793957908768	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	KRT14; KRT4; KRT20; KRT17; ABCA12;	GO:0031424~keratinization	5	181	2.76243093922652	0.00537766564904796	0.0493318512091236	1	1	0.731942106890988	0.9271750609515	0.364022431967237
up	MELTF; TACSTD2; FBLN1; EFNA5; KANK1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	6	13	46.1538461538462	0.00546647025255298	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ALOX15B; MT1E; MT1G; IGFBP5; MT1H; MT1X; PTK6;	GO:0045926~negative regulation of growth	7	18	38.8888888888889	0.00573412422377517	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PRMT5; EGFR; ERBB2; GSTP1; CEACAM1; FGFR2; EPHA2; ARHGEF5; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	9	29	31.0344827586207	0.00612677881781243	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TBX3; IFNG; CCND1; YAP1; SOX9;	GO:0030857~negative regulation of epithelial cell differentiation	5	9	55.5555555555556	0.00622797496843186	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	ELANE; ADRA2A; DIRAS2;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.00642840748546325	0.055039412661252	1	1	0.773779367433771	0.9271750609515	0.406138840524432
down	CCR2; HHEX; F2RL3;	GO:0009611~response to wounding	3	62	4.83870967741935	0.00700936657445372	0.0583464865780916	1	1	0.792669067182426	0.9271750609515	0.430541920084535
down	F13A1; PF4; FCER2; PRTN3; CCR2; BATF;	GO:0019221~cytokine-mediated signaling pathway	6	278	2.15827338129496	0.00752497150862663	0.062063755837205	1	1	0.798246143038882	0.9271750609515	0.457971853541587
up	CLDN4; MET; SFN; KDF1; GRHL3; TMEM79; TP63; GRHL1;	GO:0061436~establishment of skin barrier	8	25	32	0.008254393561692	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	HSPB1; MET; SEMA5A; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	5	10	50	0.00864871814391233	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SNAI2; PTH; RARB; BMP4; RARG; SOX9; CHADL;	GO:0032331~negative regulation of chondrocyte differentiation	7	20	35	0.00901686655682243	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PLK1; ESPL1; PTTG3P; PTTG2;	GO:0045143~homologous chromosome segregation	4	6	66.6666666666667	0.00923703831418698	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	JUP; DSP; DSG2; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00923703831418698	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PCDH17; PCDH7; MPZL2; CDH1; CEACAM1; DSG3; CEACAM6; CDH13; PCDH1; DSG2; DSC3; DSG4; NECTIN2; CADM1; PCDH18; CELSR2; CD84; PCDHGC3; IGSF9B; PCDHGB7; PCDHGB5; ROBO1; NECTIN4; MYOT; IGSF9; CDH26; CDH3; HMCN1;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	28	165	16.969696969697	0.00959247379191119	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	FGF18; EGFR; F10; ERBB2; MET; CSF3; TXN; KITLG; FGFR2; ERBB3; FGFR4; FGFR3; IGFBP5; CD80; BTC; AKR1C2; CX3CL1; SEMA5A; IL18; FAM110C; TNFAIP8L3; TRAT1; PIK3R5; HBEGF; C1QTNF1; FGF23; IL26; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	28	165	16.969696969697	0.00959247379191119	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	JUP; FUT1; EPHA1; EMP2; CDH13; CX3CL1; SKAP1; SFRP1;	GO:0001954~positive regulation of cell-matrix adhesion	8	27	29.6296296296296	0.0118882515963336	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	YAP1; TJP1; TEAD4; WWC1; TEAD3; WWTR1; TJP2; AMOTL2;	GO:0035329~hippo signaling	8	27	29.6296296296296	0.0118882515963336	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.012259432887015	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PTN; SOX9; SOX8;	GO:0060221~retinal rod cell differentiation	3	3	100	0.012259432887015	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	HOXA5; WNT5A; WNT2B;	GO:0060638~mesenchymal-epithelial cell signaling	3	3	100	0.012259432887015	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.012259432887015	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SOX9; WNT4; SOX8;	GO:0072034~renal vesicle induction	3	3	100	0.012259432887015	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMP4; EPHA2; SEMA5A; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	7	57.1428571428571	0.0134789962776842	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IGSF3; FGFR2; PAX6; SOX9;	GO:0032808~lacrimal gland development	4	7	57.1428571428571	0.0134789962776842	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	YAP1; SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.0134789962776842	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SPINK1; ANXA8; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.0134789962776842	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	CXCL11; GJB1; GATA1; ADRA2A; FGFBP2;	GO:0007267~cell-cell signaling	5	230	2.17391304347826	0.0138585796199139	0.0737210833035656	1	1	0.859231936434661	0.9271750609515	0.543991911385235
down	PROK2; CCR8; CCR2; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	4	150	2.66666666666667	0.013976152851215	0.0739091847837782	1	1	0.860914589863801	0.9271750609515	0.545379922510003
up	HPGDS; HPGD; AKR1C2; PTGR1; AKR1C4; AKR1C1;	GO:0006693~prostaglandin metabolic process	6	18	33.3333333333333	0.0182871119595088	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMPR1B; EGFR; NHLH2; TYRO3;	GO:0042698~ovulation cycle	4	8	50	0.0187802510272878	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IGFBP2; IGFBP4; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.0187802510272878	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IFNG; NPR1; NPR3; COMT; IGFBP5; PPARG; NDRG4; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	8	30	26.6666666666667	0.0193647895091981	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GHRH; WNT1; CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	5	13	38.4615384615385	0.0196063872405525	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TRIM16; TYMS; AKR1C1;	GO:0046683~response to organophosphorus	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	AKR1C4; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMP4; SOX9; SOX8;	GO:0090184~positive regulation of kidney development	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	NUPR1; MDK; YAP1;	GO:1904036~negative regulation of epithelial cell apoptotic process	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TJP1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0200096717863417	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	ELANE; KEL; CCR2;	GO:0006874~cellular calcium ion homeostasis	3	94	3.19148936170213	0.0205869279900277	0.0866306242194215	1	1	0.890454185074704	0.9271750609515	0.639252120856176
up	RARB; BMP4; BMP7; SDC1; FGFR2; SDC4; ARG2; NPNT; SFRP1;	GO:0001657~ureteric bud development	9	37	24.3243243243243	0.0214396200370126	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	SLC1A7; P2RX1; SLC26A9;	GO:0006811~ion transport	3	96	3.125	0.0217121167947922	0.0871880290701306	1	1	0.893567661246294	0.9271750609515	0.643365241778505
up	LRP4; DKK1; CALCA; MDK; SOX9; SFRP1;	GO:0030279~negative regulation of ossification	6	19	31.5789473684211	0.0222512133497432	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PRMT5; EGFR; TYMS; GLI3; IL10; CCND1; PTPN3; HAMP;	GO:0097421~liver regeneration	8	31	25.8064516129032	0.022469861510257	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	NPR1; NPR3; EDNRB; BTC; HYAL2;	GO:0035810~positive regulation of urine volume	5	14	35.7142857142857	0.0246563575934328	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CCL2; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	5	14	35.7142857142857	0.0246563575934328	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	MEIS2; EPHA2; OPRM1; P2RY1; SOX2;	GO:0070848~response to growth factor	5	14	35.7142857142857	0.0246563575934328	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	MYO1C; SNAI2; GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	5	14	35.7142857142857	0.0246563575934328	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	MATN2; CD9; P2RY1; NDN;	GO:0008347~glial cell migration	4	9	44.4444444444444	0.0252045593248966	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CCL24; HRH1; CCL7; CX3CL1; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.0267549146044672	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BIRC5; SLC26A4; SNAI2; GJB6; TFAP2A; GJB2; SLC1A3; ALDH7A1; TMPRSS3; TIMM10; ROR1; GRAP; USH1G; OTOA; MYH14; NAV2; MARVELD2; ADGRV1; SLITRK6; EPS8L2; SLC52A3; FZD4; MYO6;	GO:0007605~sensory perception of sound	23	143	16.0839160839161	0.02857744921687	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	LILRA5; ADRA2A; MMP8;	GO:0043410~positive regulation of MAPK cascade	3	109	2.75229357798165	0.02982974927586	0.0937655405559376	1	1	0.901481198969084	0.9271750609515	0.691901059281196
up	IL10; IL18; BCL6B;	GO:0042092~type 2 immune response	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GNA11; SLC45A2; DCT;	GO:0048066~developmental pigmentation	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	OXT; EDNRB; P2RY1;	GO:0060406~positive regulation of penile erection	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GJB5; GJA1; GJB2;	GO:1905867~epididymis development	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	LDLR; CRYAB; APOE;	GO:1905907~negative regulation of amyloid fibril formation	3	5	60	0.0298712900584728	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IFNG; APOE; SH3D19; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	5	15	33.3333333333333	0.0304701929539923	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMP4; HOXA5; SOX9; FOXA1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	5	15	33.3333333333333	0.0304701929539923	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	LTF; GATA1; EPCAM; AZU1; TCL1A; PROK2; NAT8B;	GO:0043066~negative regulation of apoptotic process	7	489	1.43149284253579	0.0305294389849848	0.0956305423257887	1	1	0.902483958923444	0.9271750609515	0.705663009486682
up	FGF18; EGFR; APOE; BMP4; FGFR2; FGFR4; FGFR3; OPRM1; KDR; P2RY1; CX3CL1; ARHGAP8; SLAMF1; TNFAIP8L3; NPNT; FGF23; GAREM1; TRPV4; IL26; NDRG4; GPR55; CCL8; CCL7; HMGB1P1; CCL22; CCL24; ROR2; CCL2; CCL26; NTRK2; ROR1;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	31	209	14.8325358851675	0.0309272010880031	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	NFASC; ERBB2; ERBB3; EDNRB; ALDH3A2; SOX8; PMP22;	GO:0007422~peripheral nervous system development	7	27	25.9259259259259	0.0312375812192083	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GLI3; EDN3; EDNRB; OCA2; SLC24A5; MREG;	GO:0030318~melanocyte differentiation	6	21	28.5714285714286	0.0318229283322951	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CHTF8; CDC20; POGZ; CDCA5;	GO:0007064~mitotic sister chromatid cohesion	4	10	40	0.0327951930674708	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ALOX15B; GLI3; SOX9; ANXA1;	GO:0030850~prostate gland development	4	10	40	0.0327951930674708	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EMP1; EMP2; PMP22; LPAR3;	GO:0032060~bleb assembly	4	10	40	0.0327951930674708	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CEACAM1; CDH13; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	4	10	40	0.0327951930674708	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SLC1A3; SLC1A1; CXADR; ABCG2;	GO:0070633~transepithelial transport	4	10	40	0.0327951930674708	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	AZU1; DEFA3; RNASE6; TLR8;	GO:0051607~defense response to virus	4	198	2.02020202020202	0.0335416261252384	0.0973061225662642	1	1	0.905623905381436	0.9271750609515	0.718027207852328
up	TBX3; RARB; BMP4; RARG; PITX1; ALX4; TP63;	GO:0035116~embryonic hindlimb morphogenesis	7	28	25	0.0360749136248982	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SQLE; CYB5R2; MSMO1; TM7SF2; CYP51A1;	GO:0016126~sterol biosynthetic process	5	16	31.25	0.0370753576007833	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	THY1; BMP7; IL10; CEACAM6; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	5	16	31.25	0.0370753576007833	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	NGFR; GPC1; WNT5A; WNT4; SULF1;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	5	16	31.25	0.0370753576007833	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EDN3; EDN2; EDNRB; EDNRA; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.0370753576007833	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ALOX15B; TRIM16; NME2; OVOL2; IL20;	GO:0045618~positive regulation of keratinocyte differentiation	5	16	31.25	0.0370753576007833	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TBX3; BIRC5; VEGFD; LRP5; FGF18; CLDN7; NTN1; EGFR; F2; GHRH; IFNG; KRT6A; WNT1; BMP4; RARG; EDN3; EDN2; PTN; KITLG; EPHA1; FGFR2; FGFR4; FGFR3; EDNRB; AVPR2; ALDH3A1; KDR; CEACAM6; SOX9; EFNB2; AKR1C2; CRIP2; EMP2; RAB25; IL2; CX3CL1; FOXM1; CDC20; TBX2; SLAMF1; KLF5; HES1; NTRK2; IL34; NCCRP1; SAPCD2; SFRP1; TSLP; LGMN; S100A13; OSMR; WWTR1; GAREM1; C8orf17; TRPC5; MAB21L2; HILPDA; ERBB2; ERBB3; HBEGF; PRL; BTC; CSF3;	GO:0008284~positive regulation of cell population proliferation	63	490	12.8571428571429	0.0396787708561911	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ASPDH; SDR42E2; KDM4E; PIR; SCD; PRODH; HR; FMO6P; CYP7B1; ALDH1L1; TM7SF2; CYP11A1; CYP2E1; DBH; TXN; CYP4B1; HPGD; VCAM1; MAOA; GPX3; FDXR; NOS1; ALDH3A1; PYCR1; SPR; DCT; ADH7; ALDH3B2; ALDH7A1; ALDH3A2; AKR1C2; AKR1C1; CYP24A1; PRDX4; SQLE; PTGR1; DHCR24; NSDHL; MSMO1; CYP27C1; TP53I3; PHYHD1; CYB5R2; NXN; CYP4F22; DEGS2; MOXD1; DHRS11; LDHD; TPH2; SDR16C5; CHDH; DIO2; ERO1A; DHRS1; RDH12; TXNDC17; HSD3B7; EGLN3; CYP4F11; DUOX1; STEAP1; CYP2J2; CYP2A6; STEAP3; CYP51A1; STEAP2;	GO:0055114~oxidation-reduction process	67	526	12.7376425855513	0.0404109284058614	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	F13A1; ORM1; PF4;	GO:0002576~platelet degranulation	3	124	2.41935483870968	0.0409100279689042	0.103649302519671	1	1	0.912055758487783	0.9271750609515	0.76483388014315
up	KITLG; BDKRB1; CCL8; TNFSF18;	GO:0002687~positive regulation of leukocyte migration	4	11	36.3636363636364	0.0415757294033263	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PRDX4; ERO1A; EGLN3; P4HA2;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	4	11	36.3636363636364	0.0415757294033263	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EFNA5; EPHB3; WNT4; CELSR2;	GO:0022407~regulation of cell-cell adhesion	4	11	36.3636363636364	0.0415757294033263	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.0415757294033263	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	JUP; DSP; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.0415757294033263	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
down	FABP4; TCL1A; XCL2;	GO:0071356~cellular response to tumor necrosis factor	3	125	2.4	0.0417128647914785	0.105041639909073	1	1	0.913944072687551	0.9271750609515	0.775108013997574
up	UCP1; ACOT11; ERO1A;	GO:0009266~response to temperature stimulus	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GHRH; SOX2; HES1;	GO:0021984~adenohypophysis development	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SLC1A3; TIFAB; SLITRK6;	GO:0031223~auditory behavior	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ANXA1; ANXA2; DOC2B;	GO:0031340~positive regulation of vesicle fusion	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	ID1; XDH; NOTCH4;	GO:0045602~negative regulation of endothelial cell differentiation	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PTH; FGFR4; FGF23;	GO:0055062~phosphate ion homeostasis	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMP4; BMP7; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EGFR; WNT5A; ROR2;	GO:1900020~positive regulation of protein kinase C activity	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	MYO1C; SMOC2; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	EGFR; ERBB2; LGMN;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.0418219347267144	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	FOXP2; LRP5; FGFR2; WNT5A; SOX9; PRRX1;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.0437312191571694	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IL2RA; IGFBP2; CD24; IL2; IL18; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	6	23	26.0869565217391	0.0437312191571694	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	PRMT5; PTN; MDK; PPARG; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	6	23	26.0869565217391	0.0437312191571694	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TJP1; TRPV4; CDH1; CDH3; PKP2; PKP3; CDH13; CTNND1; CDH26;	GO:0007043~cell-cell junction assembly	9	43	20.9302325581395	0.0439341978761518	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SNAI2; EGFR; ERBB2; GSTP1; ID1; SOX9; SKAP1; GAREM1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	9	43	20.9302325581395	0.0439341978761518	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	KRT6A; SERPINB5; RIPK4; SOX9; SOX8;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.044491264583743	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	GLRA1; C11orf74; SYT8; ROPN1B; TNP2;	GO:0007340~acrosome reaction	5	17	29.4117647058824	0.044491264583743	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	APOE; APOA2; CETP; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	5	17	29.4117647058824	0.044491264583743	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	TRPA1; CALCA; DBH; COMT; EDNRB;	GO:0048265~response to pain	5	17	29.4117647058824	0.044491264583743	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	BMPR1B; BMP4; MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	5	17	29.4117647058824	0.044491264583743	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	IFITM5; LRP5; TFAP2A; FGFR2; FGFR3; RARG; RARB;	GO:0060349~bone morphogenesis	7	30	23.3333333333333	0.0471686618260552	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CCL22; BIRC5; IL2RA; ANXA1; CSF3; GHR; CCL2; MUC1; IL1RN; SDC1; VCAM1; EDN2; MAOA; IL10; CCND1; CD80; IL13; OPRM1; SOX2; RORC; CCR5; IL2; CX3CL1; IL18; IRF4; IL20RB; IL34; IL22RA1; NDN; OSMR; IL22; IL1RL2; IL26; DUOX1; IL20; IL36A; FZD4; IFNA5;	GO:0019221~cytokine-mediated signaling pathway	38	278	13.6690647482014	0.0484477140905827	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	CALCA; ANXA1; CCL2; CCL7; CCL26; CX3CL1; CCL22; CCL8; CCL24;	GO:0002548~monocyte chemotaxis	9	44	20.4545454545455	0.0488072976594446	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
up	SULT2B1; NR1I2; CYP2E1; CYP2A6; AKR1C2; MSMO1; DHCR24; AKR1C1; AKR1C4;	GO:0008202~steroid metabolic process	9	44	20.4545454545455	0.0488072976594446	0.731647016726967	1	1	0.999999999995672	0.999999999995672	1
